Science 17 November 1989: Vol. 246. no. 4932, pp. 904 - 910 DOI: 10.1126/science.2530631

Prev | Table of Contents | Next

Articles

Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).

Y.-T. Wang, A. von Zychlinski, and S. P. A. McCormick (2009)
J. Lipid Res. 50, 846-853
 |  Abstract »  |  Full Text »  |  PDF »

Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study.

S. Tsimikas, P. Clopton, E. S. Brilakis, S. M. Marcovina, A. Khera, E. R. Miller, J. A. de Lemos, and J. L. Witztum (2009)
Circulation 119, 1711-1719
 |  Abstract »  |  Full Text »  |  PDF »

Ethnicity and peripheral artery disease.

P.C. Bennett, S. Silverman, P.S. Gill, and G.Y.H. Lip (2009)
QJM 102, 3-16
 |  Abstract »  |  Full Text »  |  PDF »

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.

C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E. R. Miller, M.-J. Shin, C. J. Binder, S. Horkko, R. M. Krauss, M. J. Chapman, et al. (2008)
J. Lipid Res. 49, 2230-2239
 |  Abstract »  |  Full Text »  |  PDF »

Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Cohort.

J. D. Sturgeon, A. R. Folsom, W.T. Longstreth Jr, E. Shahar, W. D. Rosamond, and M. Cushman (2008)
Stroke 39, 2268-2273
 |  Abstract »  |  Full Text »  |  PDF »

Role of Lipoprotein(a) in Cardiovascular Disease: Current and Future Perspectives.

L. Berglund and E. Anuurad (2008)
J. Am. Coll. Cardiol. 52, 132-134
 |  Full Text »  |  PDF »

High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans.

E. Anuurad, J. Rubin, A. Chiem, R. P. Tracy, T. A. Pearson, and L. Berglund (2008)
J. Clin. Endocrinol. Metab. 93, 1482-1488
 |  Abstract »  |  Full Text »  |  PDF »

Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study.

P. R. Kamstrup, M. Benn, A. Tybjaerg-Hansen, and B. G. Nordestgaard (2008)
Circulation 117, 176-184
 |  Abstract »  |  Full Text »  |  PDF »

Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial Disease.

B. Dieplinger, A. Lingenhel, N. Baumgartner, W. Poelz, H. Dieplinger, M. Haltmayer, F. Kronenberg, and T. Mueller (2007)
Clin. Chem. 53, 1298-1305
 |  Abstract »  |  Full Text »  |  PDF »

Plasma Lipoprotein(a) Indicates Risk for 4 Distinct Forms of Vascular Disease.

G. T. Jones, A. M. van Rij, J. Cole, M. J.A. Williams, E. H. Bateman, S. M. Marcovina, M. Deng, and S. P.A. McCormick (2007)
Clin. Chem. 53, 679-685
 |  Abstract »  |  Full Text »  |  PDF »

ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study.

E. Anuurad, G. Lu, J. Rubin, T. A. Pearson, and L. Berglund (2007)
J. Lipid Res. 48, 693-698
 |  Abstract »  |  Full Text »  |  PDF »

Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up.

B. Wiberg, J. Sundstrom, J. Arnlov, A. Terent, B. Vessby, B. Zethelius, and L. Lind (2006)
Stroke 37, 2898-2903
 |  Abstract »  |  Full Text »  |  PDF »

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline..

L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. (2006)
Circulation 113, e873-e923
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study.

T. Ohira, P. J. Schreiner, J. D. Morrisett, L. E. Chambless, W. D. Rosamond, and A. R. Folsom (2006)
Stroke 37, 1407-1412
 |  Abstract »  |  Full Text »  |  PDF »

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline..

L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. (2006)
Stroke 37, 1583-1633
 |  Abstract »  |  Full Text »  |  PDF »

Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a].

J. Rubin, H. J. Kim, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund (2006)
J. Lipid Res. 47, 982-989
 |  Abstract »  |  Full Text »  |  PDF »

An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo.

C. M. Devlin, S.-J. Lee, G. Kuriakose, C. Spencer, L. Becker, I. Grosskopf, C. Ko, L.-S. Huang, M. L. Koschinsky, A. D. Cooper, et al. (2005)
Arterioscler. Thromb. Vasc. Biol. 25, 1704-1710
 |  Abstract »  |  Full Text »  |  PDF »

Prospective Study of Lipoprotein(a) as a Risk Factor for Deteriorating Renal Function in Type 2 Diabetic Patients With Overt Proteinuria.

K.-H. Song, S. H. Ko, H.-W. Kim, Y.-B. Ahn, J.-M. Lee, H.-S. Son, K.-H. Yoon, B.-Y. Cha, K.-W. Lee, and H.-Y. Son (2005)
Diabetes Care 28, 1718-1723
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study.

R. Guerra, Z. Yu, S. Marcovina, R. Peshock, J. C. Cohen, and H. H. Hobbs (2005)
Circulation 111, 1471-1479
 |  Abstract »  |  Full Text »  |  PDF »

Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly.

R. J. Sharp, M. A. Perugini, S. M. Marcovina, and S. P. A. McCormick (2004)
J. Lipid Res. 45, 2227-2234
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a): An Elusive Cardiovascular Risk Factor.

L. Berglund and R. Ramakrishnan (2004)
Arterioscler. Thromb. Vasc. Biol. 24, 2219-2226
 |  Abstract »  |  Full Text »  |  PDF »

High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis.

J. F. Arenillas, C. A. Molina, P. Chacon, A. Rovira, J. Montaner, P. Coscojuela, E. Sanchez, M. Quintana, and J. Alvarez-Sabin (2004)
Neurology 63, 27-32
 |  Abstract »  |  Full Text »  |  PDF »

Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.

K. Ikewaki, W. Cain, F. Thomas, R. Shamburek, L. A. Zech, D. Usher, H. B. Brewer Jr., and D. J. Rader (2004)
J. Lipid Res. 45, 1302-1311
 |  Abstract »  |  Full Text »  |  PDF »

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

F Hartgens, G Rietjens, H A Keizer, H Kuipers, and B H R Wolffenbuttel (2004)
Br. J. Sports Med. 38, 253-259
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) Is an Independent Risk Factor for Peripheral Arterial Disease in Chinese Type 2 Diabetic Patients in Taiwan.

C.-H. Tseng (2004)
Diabetes Care 27, 517-521
 |  Abstract »  |  Full Text »  |  PDF »

Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.

C. Y. Y. Liu, R. Broadhurst, S. M. Marcovina, and S. P. A. McCormick (2004)
J. Lipid Res. 45, 63-70
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of the Expression of the Apolipoprotein(a) Gene: Evidence for a Regulatory Role of the 5' Distal Apolipoprotein(a) Transcription Control Region Enhancer in Yeast Artificial Chromosome Transgenic Mice.

T. Huby, V. Afzal, C. Doucet, R. M. Lawn, E. L. Gong, M. J. Chapman, J. Thillet, and E. M. Rubin (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 1633-1639
 |  Abstract »  |  Full Text »  |  PDF »

Lack of genetic linkage evidence for a trans-acting factor having a large effect on plasma lipoprotein[a] levels in African Americans.

R. A. Barkley, A. C. Brown, C. L. Hanis, S. L. Kardia, S. T. Turner, and E. Boerwinkle (2003)
J. Lipid Res. 44, 1301-1305
 |  Abstract »  |  Full Text »  |  PDF »

Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial.

J. Sabate, E. Haddad, J. S Tanzman, P. Jambazian, and S. Rajaram (2003)
Am. J. Clinical Nutrition 77, 1379-1384
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein[a] secretion from hepatoma cells is regulated in a size-dependent manner by alterations in disulfide bond formation.

F. Nassir, Y. Xie, and N. O. Davidson (2003)
J. Lipid Res. 44, 816-827
 |  Abstract »  |  Full Text »  |  PDF »

A Synthetic Peptide That Inhibits Lipoprotein(a) Assembly.

R. J. Sharp, M. A. Perugini, S. M. Marcovina, and S. P.A. McCormick (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 502-507
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Aspirin Treatment on Serum Concentrations of Lipoprotein(a) in Patients with Atherosclerotic Diseases.

M. Akaike, H. Azuma, A. Kagawa, K. Matsumoto, I. Hayashi, K. Tamura, T. Nishiuchi, T. Iuchi, N. Takamori, K.-i. Aihara, et al. (2002)
Clin. Chem. 48, 1454-1459
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

J. Rubin, F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund (2002)
J. Lipid Res. 43, 234-244
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) Promotes Smooth Muscle Cell Proliferation and Dedifferentiation in Atherosclerotic Lesions of Human Apo(a) Transgenic Rabbits.

T. Ichikawa, H. Unoki, H. Sun, H. Shimoyamada, S. Marcovina, H. Shikama, T. Watanabe, and J. Fan (2002)
Am. J. Pathol. 160, 227-236
 |  Abstract »  |  Full Text »  |  PDF »

Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene.

J. Rubin, T. A. Pearson, R. G. Reed, and L. Berglund (2001)
Clin. Chem. 47, 1758-1762
 |  Abstract »  |  Full Text »  |  PDF »

Plasma Apolipoprotein(a) Co-Deposits with Fibrin in Inflammatory Arthritic Joints.

N. Busso, J. Dudler, R. Salvi, V. Peclat, V. Lenain, S. Marcovina, R. Darioli, P. Nicod, A. K. So, and V. Mooser (2001)
Am. J. Pathol. 159, 1445-1453
 |  Abstract »  |  Full Text »

Instability of Lipoprotein(a) in Plasma Stored at -70 {degrees}C : Effects of Concentration, Apolipoprotein(a) Genotype, and Donor Cardiovascular Disease.

J. M. Simo, J. Camps, E. Vilella, F. Gomez, A. Paul, and J. Joven (2001)
Clin. Chem. 47, 1673-1678
 |  Abstract »  |  Full Text »  |  PDF »

Serum Homocysteine and Lipoprotein (a) Concentrations in Hypercholesterolemic and Normocholesterolemic Children.

T. Laskowska-Klita, E. Szymczak, and B. Radomyska (2001)
Clinical Pediatrics 40, 149-154
 |  Abstract »  |  PDF »

Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH.

G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino (2001)
Hum. Reprod. 16, 449-456
 |  Abstract »  |  Full Text »  |  PDF »

Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review.

F. B. Hu, J. E. Manson, and W. C. Willett (2001)
J. Am. Coll. Nutr. 20, 5-19
 |  Abstract »  |  Full Text »  |  PDF »

Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures.

J. Wang, J. Boedeker, H. H. Hobbs, and A. L. White (2001)
J. Lipid Res. 42, 60-69
 |  Abstract »  |  Full Text »

Transgenic Rabbits Expressing Human Apolipoprotein(a) Develop More Extensive Atherosclerotic Lesions in Response to a Cholesterol-Rich Diet.

J. Fan, H. Shimoyamada, H. Sun, S. Marcovina, K. Honda, and T. Watanabe (2001)
Arterioscler. Thromb. Vasc. Biol. 21, 88-94
 |  Abstract »  |  Full Text »  |  PDF »

High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men.

F. Paultre, T. A. Pearson, H. F. C. Weil, C. H. Tuck, M. Myerson, J. Rubin, C. K. Francis, H. F. Marx, E. F. Philbin, R. G. Reed, et al. (2000)
Arterioscler. Thromb. Vasc. Biol. 20, 2619-2624
 |  Abstract »  |  Full Text »  |  PDF »

Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding.

A. Hrzenjak, S. Frank, B. Maderegger, H. Sterk, and G.M. Kostner (2000)
Protein Eng. Des. Sel. 13, 661-666
 |  Abstract »  |  Full Text »  |  PDF »

Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein and cholesterol.

N. Lindbohm, H. Gylling, and T. A. Miettinen (2000)
J. Lipid Res. 41, 1110-1117
 |  Abstract »  |  Full Text »

Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a].

J. Fan, M. Challah, H. Shimoyamada, M. Shiomi, S. Marcovina, and T. Watanabe (2000)
J. Lipid Res. 41, 1004-1012
 |  Abstract »  |  Full Text »

A quantitative assay for the non-covalent association between apolipoprotein[a] and apolipoprotein B: an alternative measure of Lp[a] assembly.

B. N. Dardik, C. D. Schwartzkopf, D. E. Stevens, and R. E. Chatelain (2000)
J. Lipid Res. 41, 1013-1019
 |  Abstract »  |  Full Text »

Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease.

V. Mooser, N. Helbecque, J. Miklossy, S. M. Marcovina, P. Nicod, and P. Amouyel (2000)
Ann Intern Med 132, 533-537
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm.

K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue (2000)
J. Am. Coll. Cardiol. 35, 1200-1205
 |  Abstract »  |  Full Text »  |  PDF »

Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns.

V. Mooser, M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero (2000)
Arterioscler. Thromb. Vasc. Biol. 20, 1137-1142
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis.

F I Romero, M A Khamashta, and G R. Hughes (2000)
Lupus 9, 206-209
 |  Abstract »  |  PDF »

Lipoprotein(a): from ancestral benefit to modern pathogen?.

G. Lippi and G. Guidi (2000)
QJM 93, 75-84
 |  Abstract »  |  Full Text »  |  PDF »

Dissecting the Genetic Architecture of Lipids, Lipoproteins, and Apolipoproteins : Lessons From Twin Studies.

H. Snieder, L. J. P. van Doornen, and D. I. Boomsma (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 2826-2834
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood.

U. Nowak-Gottl, R. Strater, A. Heinecke, R. Junker, H.-G. Koch, G. Schuierer, and A. von Eckardstein (1999)
Blood 94, 3678-3682
 |  Abstract »  |  Full Text »  |  PDF »

Aspirin Reduces Apolipoprotein(a) (Apo(a)) Production in Human Hepatocytes by Suppression of Apo(a) Gene Transcription.

A. Kagawa, H. Azuma, M. Akaike, Y. Kanagawa, and T. Matsumoto (1999)
J. Biol. Chem. 274, 34111-34115
 |  Abstract »  |  Full Text »  |  PDF »

Increased Prevalence of Smaller and Denser LDL Particles in Asian Indians.

K. R. Kulkarni, J. H. Markovitz, N. C. Nanda, and J. P. Segrest (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 2749-2755
 |  Abstract »  |  Full Text »  |  PDF »

Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors.

D. Periard, A. Telenti, P. Sudre, J.-J. Cheseaux, P. Halfon, M. J. Reymond, S. M. Marcovina, M. P. Glauser, P. Nicod, R. Darioli, et al. (1999)
Circulation 100, 700-705
 |  Abstract »  |  Full Text »  |  PDF »

Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood.

U. Nowak-Gottl, R. Junker, M. Hartmeier, H.-G. Koch, N. Munchow, G. Assmann, and A. von Eckardstein (1999)
Circulation 100, 743-748
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study.

L. J. Seman, C. DeLuca, J. L. Jenner, L. A. Cupples, J. R. McNamara, P. W.F. Wilson, W. P. Castelli, J. M. Ordovas, and E. J. Schaefer (1999)
Clin. Chem. 45, 1039-1046
 |  Abstract »  |  Full Text »  |  PDF »

Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a).

J. Svensson, J.-O. Jansson, M. Ottosson, G. Johannsson, M.-R. Taskinen, O. Wiklund, and B.-A. Bengtsson (1999)
J. Clin. Endocrinol. Metab. 84, 2028-2033
 |  Abstract »  |  Full Text »

Optimization of Apolipoprotein(a) Genotyping with Pulsed Field Gel Electrophoresis.

P. H. Griffioen, L. Zwang, R. H.N. van Schaik, H. Engel, J. Lindemans, and C. M. Cobbaert (1999)
Clin. Chem. 45, 771-776
 |  Abstract »  |  Full Text »  |  PDF »

Estrogen Modulation of Apolipoprotein(a) Expression. IDENTIFICATION OF A REGULATORY ELEMENT.

D. Boffelli, D. A. Zajchowski, Z. Yang, and R. M. Lawn (1999)
J. Biol. Chem. 274, 15569-15574
 |  Abstract »  |  Full Text »  |  PDF »

6-Aminohexanoic Acid as a Chemical Chaperone for Apolipoprotein(a).

J. Wang and A. L. White (1999)
J. Biol. Chem. 274, 12883-12889
 |  Abstract »  |  Full Text »  |  PDF »

Growth Hormone (GH) Therapy in GH-Deficient Adults Influences the Response to a Dietary Load of Cholesterol and Saturated Fat in Terms of Cholesterol Synthesis, But Not Serum Low Density Lipoprotein Cholesterol Levels.

M. Leonsson, J. Oscarsson, I. Bosaeus, B. K. Lundgren, G. Johannsson, O. Wiklund, and B. A. Bengtsson (1999)
J. Clin. Endocrinol. Metab. 84, 1296-1303
 |  Abstract »  |  Full Text »

Effect of Lp(a) on the Early Functional and Structural Changes of Atherosclerosis.

O. T. Raitakari, M. R. Adams, and D. S. Celermajer (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 990-995
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments.

V. Mooser, F. Tinguely, P. Fontana, V. Lenain, M. Vaglio, P. Ruchat, L. K. von Segesser, S. M. Marcovina, M. Markert, R. Darioli, et al. (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 1060-1065
 |  Abstract »  |  Full Text »  |  PDF »

Dose-Dependent Inverse Relationship Between Alcohol Consumption and Serum Lp(a) Levels in Black African Males.

P. Fontana, V. Mooser, P. Bovet, C. Shamlaye, B. Burnand, V. Lenain, S. M. Marcovina, W. Riesen, and R. Darioli (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 1075-1082
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) in Acromegaly.

P. Maffei, N. Sicolo, and M. Plebani (1999)
Ann Intern Med 130, 537-538
 |  Full Text »  |  PDF »

Lipoprotein(a) and coronary thrombosis and restenosis after stent placement.

A. Wehinger, A. Kastrati, S. Elezi, H. Baum, S. Braun, F.-J. Neumann, and A. Schomig (1999)
J. Am. Coll. Cardiol. 33, 1005-1012
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Basis of the Interaction between Plasma Platelet-activating Factor Acetylhydrolase and Low Density Lipoprotein.

D. M. Stafforini, L. W. Tjoelker, S. P. A. McCormick, D. Vaitkus, T. M. McIntyre, P. W. Gray, S. G. Young, and S. M. Prescott (1999)
J. Biol. Chem. 274, 7018-7024
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro.

A. Niemeier, T. Willnow, H. Dieplinger, C. Jacobsen, N. Meyer, J. Hilpert, and U. Beisiegel (1999)
Arterioscler. Thromb. Vasc. Biol. 19, 552-561
 |  Abstract »  |  Full Text »  |  PDF »

Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway.

A. L. White, B. Guerra, J. Wang, and R. E. Lanford (1999)
J. Lipid Res. 40, 275-286
 |  Abstract »  |  Full Text »

{beta}2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels.

J George, B Gilburd, P Langevitz, Y Levy, R Nezlin, D Harats, and Y Shoenfeld (1999)
Lupus 8, 116-120
 |  Abstract »  |  PDF »

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.

E. Sbarouni, Z. S. Kyriakides, and D. T. Kremastinos (1998)
J. Am. Coll. Cardiol. 32, 1244-1250
 |  Abstract »  |  Full Text »  |  PDF »

Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.

X. J. Lou, N. W. Boonmark, F. T. Horrigan, J. L. Degen, and R. M. Lawn (1998)
PNAS 95, 12591-12595
 |  Abstract »  |  Full Text »  |  PDF »

Plasma Lipoprotein(a) Is Not a Predictor for Restenosis After Elective High-Pressure Coronary Stenting.

F. Ribichini, G. Steffenino, A. Dellavalle, A. Vado, V. Ferrero, T. Camilla, S. Giubergia, and E. Uslenghi (1998)
Circulation 98, 1172-1177
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.

D. K. Bonen, F. Nassir, A. M. L. Hausman, and N. O. Davidson (1998)
J. Lipid Res. 39, 1629-1640
 |  Abstract »  |  Full Text »

Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion.

F. Nassir, D. K. Bonen, and N. O. Davidson (1998)
J. Biol. Chem. 273, 17793-17800
 |  Abstract »  |  Full Text »  |  PDF »

Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors.

S. Donazzan, D. Monti, D. Mari, S. Martini, C. Gabelli, M. D. Vestra, L. Previato, M. Guido, S. Pigozzo, I. Cortella, et al. (1998)
FASEB J 12, 433-437
 |  Abstract »  |  Full Text »

Increased Degradation of Lipoprotein(a) in Atherosclerotic Compared With Nonlesioned Aortic Intima–Inner Media of Rabbits : In Vivo Evidence That Lipoprotein(a) May Contribute to Foam Cell Formation.

L. B. Nielsen, K. Juul, and B. G. Nordestgaard (1998)
Arterioscler. Thromb. Vasc. Biol. 18, 641-649
 |  Abstract »  |  Full Text »  |  PDF »

Alcohol Withdrawal–Induced Change in Lipoprotein(a) : Association With the Growth Hormone/Insulin-like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis.

M. Paassilta, K. Kervinen, M. Linnaluoto, and Y. A. Kesaniemi (1998)
Arterioscler. Thromb. Vasc. Biol. 18, 650-654
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein(a) Gene Enhancer Resides within a LINE Element.

Z. Yang, D. Boffelli, N. Boonmark, K. Schwartz, and R. Lawn (1998)
J. Biol. Chem. 273, 891-897
 |  Abstract »  |  Full Text »  |  PDF »

Apolipoprotein(a) Yeast Artificial Chromosome Transgenic Rabbits. LIPOPROTEIN(a) ASSEMBLY WITH HUMAN AND RABBIT APOLIPOPROTEIN B.

D. Rouy, N. Duverger, S. D. Lin, F. Emmanuel, L.-M. Houdebine, P. Denefle, C. Viglietta, E. Gong, E. M. Rubin, and S. D. Hughes (1998)
J. Biol. Chem. 273, 1247-1251
 |  Abstract »  |  Full Text »  |  PDF »

Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I).

W. F. Baker JR (1998)
Clinical and Applied Thrombosis/Hemostasis 4, 51-75
 |  Abstract »  |  PDF »

Oral 17{beta}-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women.

V. Mijatovic, P. Kenemans, J. C. Netelenbos, E. R. A. Peters-Muller, G. J. van Kamp, G. A. Voetberg, P. H. M. van de Weijer, and M. J. van der Mooren (1997)
J. Clin. Endocrinol. Metab. 82, 3543-3547
 |  Abstract »  |  Full Text »  |  PDF »

Convergent evolution of apolipoprotein(a) in primates and hedgehog.

R. M. Lawn, K. Schwartz, and L. Patthy (1997)
PNAS 94, 11992-11997
 |  Abstract »  |  Full Text »  |  PDF »

Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease.

W.-K. Min, J. O. Lee, and J. W. Huh (1997)
Clin. Chem. 43, 1891-1895
 |  Abstract »  |  Full Text »  |  PDF »

Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a).

S. P. A. McCormick, J. K. Ng, C. M. Cham, S. Taylor, S. M. Marcovina, J. P. Segrest, R. E. Hammer, and S. G. Young (1997)
J. Biol. Chem. 272, 23616-23622
 |  Abstract »  |  Full Text »  |  PDF »

Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice.

B. R. Zysow, K. Kauser, R. M. Lawn, and G. M. Rubanyi (1997)
Arterioscler. Thromb. Vasc. Biol. 17, 1741-1745
 |  Abstract »  |  Full Text »

Lipoprotein(a) Is a Potent Chemoattractant for Human Peripheral Monocytes.

T. Syrovets, J. Thillet, M. J. Chapman, and T. Simmet (1997)
Blood 90, 2027-2036
 |  Abstract »  |  Full Text »  |  PDF »

Novel Interaction of Apolipoprotein(a) With beta -2 Glycoprotein I Mediated by the Kringle IV Domain.

S. Kochl, F. Fresser, E. Lobentanz, G. Baier, and G. Utermann (1997)
Blood 90, 1482-1489
 |  Abstract »  |  Full Text »  |  PDF »

Association of Serum Lipoprotein(a) Levels and Apolipoprotein(a) Size Polymorphism With Target-Organ Damage in Arterial Hypertension.

L. A. Sechi, F. Kronenberg, S. De Carli, E. Falleti, L. Zingaro, C. Catena, G. Utermann, and E. Bartoli (1997)
JAMA 277, 1689-1695
 |  Abstract »  |  PDF »

Lipoprotein (a): Its Role in Childhood Thromboembolism.

U. Nowak-Gottl, O. Debus, M. Findeisen, R. Kassenbohmer, H. G. Koch, H. Pollmann, C. Postler, P. Weber, and H. Vielhaber (1997)
Pediatrics 99, e11
 |  Abstract »  |  Full Text »  |  PDF »

Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells. EVIDENCE FOR INTRACELLULAR ASSEMBLY OF LIPOPROTEIN(a).

D. K. Bonen, A. M.L. Hausman, C. Hadjiagapiou, S. F. Skarosi, and N. O. Davidson (1997)
J. Biol. Chem. 272, 5659-5667
 |  Abstract »  |  Full Text »  |  PDF »

Influence of Allelic Variation on Apolipoprotein(a) Folding in the Endoplasmic Reticulum.

A. L. White, B. Guerra, and R. E. Lanford (1997)
J. Biol. Chem. 272, 5048-5055
 |  Abstract »  |  Full Text »  |  PDF »

A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants.

S. H. Wild, S. P. Fortmann, and S. M. Marcovina (1997)
Arterioscler. Thromb. Vasc. Biol. 17, 239-245
 |  Abstract »  |  Full Text »

Platelet Integrin {alpha}IIbß3 (GPIIb-IIIa) Is Not Implicated in the Binding of LDL to Intact Resting Platelets.

J. Pedreno, R. Fernandez, C. Cullare, A. Barcelo, M. A. Elorza, and C. de Castellarnau (1997)
Arterioscler. Thromb. Vasc. Biol. 17, 156-163
 |  Abstract »  |  Full Text »

The Binding Activity of the Macrophage Lipoprotein(a)/Apolipoprotein(a) Receptor Is Induced by Cholesterol via a Post-translational Mechanism and Recognizes Distinct Kringle Domains on Apolipoprotein(a).

G. A. Keesler, B. R. Gabel, C. M. Devlin, M. L. Koschinsky, and I. Tabas (1996)
J. Biol. Chem. 271, 32096-32104
 |  Abstract »  |  Full Text »  |  PDF »

The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells.

C. Brunner, E.-M. Lobentanz, A. Petho-Schramm, A. Ernst, C. Kang, H. Dieplinger, H.-J. Muller, and G. Utermann (1996)
J. Biol. Chem. 271, 32403-32410
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products